Antimicrobial effects of arginine and nitrogen oxides and their potential role in sepsis

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 9, Issue 3, 2006, Pages 225-232

  Hardy, Ines ^a   Alany, Raid ^a   Russell, Bruce ^a   Hardy, Gil ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITROGEN OXIDE; OMEGA 3 FATTY ACID;

ANTIMICROBIAL ACTIVITY; CRITICAL ILLNESS; CYTOKINE PRODUCTION; ENDOTOXEMIA; ESCHERICHIA COLI; FRANCISELLA TULARENSIS; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE INFECTION; HOST RESISTANCE; HUMORAL IMMUNITY; LEISHMANIA; MACROPHAGE ACTIVATION; METABOLIC REGULATION; NONHUMAN; NUTRIENT MANAGEMENT; NUTRIENT SUPPLY; PROTEIN METABOLISM; PROTEIN VARIANT; PSEUDOMONAS AERUGINOSA; REVIEW; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 33746253850     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: None     Document Type: Article

References (95)

1. Nakagawa I, Takahashi T, Suzuki T. Amino acid requirements of children: minimal needs of tryptophan, arginine, histidine based on nitrogen balance method. J Nutr 1963; 80:350.
2. Visek WJ. Arginine needs, physiological state and usual diets: a reevaluation. J Nutr 1986; 116:36-46.
3. Argaman Z, Young VR, Noviski N, et al. Arginine and nitric oxide metabolism in critically ill septic pedatric patients. Crit Care Med 2003; 31:591-597.
4. Luiking Y, Poeze M, Ramsay G, et al. The role of arginine in infection and sepsis. Journal of Parenteral and Enteral Nutrition 2005; 29:S70-S74. A very good review that puts forward the argument that arginine is an essential amino acid in sepsis and infection.
5. Wells BJ, Mainous AG 3rd, Everett CJ. Association between dietary arginine and C-reactive protein. Nutrition 2005; 21:125-130.
6. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336 (Pt 1):1-17.
7. Castillo L, Beaumier L, Ajami A, et al. Whole body nitric oxide synthesis in healthy men determined from [15N]arginine-to[15N]citrulline labelling. Proc Natl Acad Sci USA 1996; 93:11460-11465.
8. Knowles RG, Moncada S. Nitric oxide synthase in mammals. Biochem J 1994; 298:249-258.
9. Fang F. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997; 99:2818-2825.
10. Adams LB, Hibbs JB Jr, Taintor RR, et al. Microbiostatic effect of murine activated macrophages for Toxoplasma gondii. J Immunol 1990; 144:2725-2729.
11. Fang F. Nitric Oxide and Infection. New York Kluwer Academic/Plenum Press 1999.
12. Tsai WC, Strieter RM, Zisman DA, et al. Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect Immun 1997; 65:1870-1875.
13. Eckmann L, Laurent F, Langford TD, et al. Nitric oxide production by human intestinal epithelial cells and competition for arginine as potential determinants of host defense against the lumen-dwelling pathogen Giardia lamblia. J Immunol 2000; 164:1478-1487.
14. Anstey NM, Weinberg JB, Hassanali MY, et al. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 1996; 184:557-567.
15. Evans TG, Thai L, Granger DL, et al. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J Immunol 1993; 151:907-915.
16. Gobert AP, Daulouede S, Lepoivre M, et al. L-arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis. Infect Immun 2000; 68:4653-4657.
17. Anthony LSD, Morrissey PJ, Nano FE. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. J Immunol 1992; 148:1829-1834.
18. Darling KEA, Evans TJ. Effects of nitric oxide on Pseudomonas aeruginosa infection of epithelial cells from a human respiratory cell line derived from a patient with cystic fibrosis. Infect Immun 2003; 71:2341-2349.
19. Taylor-Robinson AW, Phillips RS, Severn A, et al. The role of TH1 and TH2 cells in a rodent malaria infection. Science 1993; 260:1931-1934.
20. Petray P, Castanos-Velez E, Grinstein S, et al. Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi. Immunol Lett 1995; 47:121-123.
21. Pacelli R, Wink DA, Cook JA, et al. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J Exp Med 1995; 182:1469-1479.
22. Hardwick JB, Tucker AT, Wilks M, et al. A novel method for the delivery of nitric oxide therapy to the skin of human subjects using a semi-permeable membrane. Clin Sci (Colch) 2001; 100:395-400.
23. Weller R, Price RJ, Ormerod AD, et al. Antimicrobial effect of acidified nitrite on dermatophyte fungi, Candida and bacterial skin pathogens. J Appl Microbiol 2001; 90:648-652.
24. Eriksson S, Chambers BJ, Rhen M. Nitric oxide produced by murine dendritic cells is cytotoxic for intracellular Salmonella enterica sv. Typhimurium. Scand J Immunol 2003; 58:493-502.
25. Alspaugh JA, Granger DL. Inhibition of Cryptococcus neoformans by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect Immun 1991; 59:2291-2296.
26. Agawa H, Ikuta K, Minamiyama Y, et al. Down-regulation of spontaneous Epstein-Barr virus reactivation in the P3HR-1 cell line by L-arginine. Virology 2002; 304:114-124.
27. Takada H, Kishimoto C, Hiraoka Y, et al. Oral L-arginine prevents murine coxsackievirus B3 myocarditis. Int J Cardiol 2002; 86:373-379.
28. Bi Z, Reiss CS. Inhibition of vesicular stomatitis virus infection by nitric oxide. J Virol 1995; 69:2208-2213.
29. Bertholet S, Tzeng E, Felley-Bosco E, et al. Expression of inducible NO synthase in human monocytic U937 cells allows high output nitric oxide production. J Leukoc Biol 1999; 65:50-58.
30. Sternberg J, Mabbott N, Sutherland I, et al. Inhibition of nitric oxide synthesis leads to reduced parasitemia in murine Trypanosoma brucei infection. Infect Immun 1994; 62:2135-2137.
31. Gow AJ, Luchsinger BP, Pawloski JR. The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci U S A 1999; 96:9027-9032.
32. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992; 258:1898-1902.
33. Lindgren H, Stenman L, Tarnvik A, et al. The contribution of reactive nitrogen and oxygen species to the killing of Francisella tularensis LVS by murine macrophages. Microbes Infect 2005; 7:467-475.
34. Vouldokis I, Riveros-Moreno V, Dugas B, et al. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FceRII/CD23 surface antigen. Proc Natl Acad Sci USA 1995; 92:7804-7808.
35. DeMaria R, Cifone MG, Trotta R, et al. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 1994; 180:1999-2004.
36. Bukrinsky MI, Nottet HSLM, Schmidtmayerova H, et al. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995; 181:735-745.
37. Evans TG, Buttery LDK, Carpenter A, et al. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc Natl Acad Sci USA 1996; 93:9553-9558.
38. Wheeler MA, Smith SD, Garcia-Cardena G, et al. Bacterial infection induces nitric oxide synthase in human neutrophils. J Clin Invest 1997; 99:110-116.
39. Nicholson S, Bonecini-Almeida MDG, Lapa e Silva JR, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996; 183:2293-2302.
40. St Clair EW, Wilkinson WE, Lang T, et al. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J Exp Med 1996; 184:1173-1178.
41. Nathan CF, Hibbs JB Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3:65-70.
42. Hibbs JB Jr, Taintor RR, Vavrin Z, et al. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157:87-94.
43. Cher DJ, Mosmann T. Two types of murine helper cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 1987; 138:3688-3694.
44. Cherwinski HM, Schuhmacher JH, Brown KD, Mosmann TR. Two types of murine helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridisation, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987; 166:1229-1244.
45. Mosmann T, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-173.
46. Barbul A, Sisto M, Wasserkrug HL. Arginine stimulates lymphocyte immune responses in healthy humans. Surgery 1981; 90:244-251.
47. Ochoa JB, Strange J, Kearney P. Effects of L-arginine on the proliferation of T lymphocyte subpopulations. J Parenter Enteral Nutr 2001; 25:23-29.
48. Wigand R, Meyer J, Busse R, et al. Increased serum NG-hydroxy-L-arginine in patients with rheumatoid arthritis and systemic lupus erythematosus as an index of increased nitric oxide synthase activity. Ann Rheum Dis 1997; 56:330-332.
49. Bansal V, Ochoa JB. Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care 2003; 6:223-228.
50. Freund H, Atamian S, Holroyde J. Plasma amino acids as predictors of the severity and outcome of sepsis. Ann Surg 1979; 190:571-576.
51. Manders S, Poeze M, Ramsay G. Plasma nitrate in surviving patients with septic shock are increased compared to non-survivors. Intensive Care Med 1999; 25:S86.
52. Gianotti L, Braga M, Fortis C. A prospective randomised clinical trial on perioperative feeding with arginine-, omega-3 fatty acid, and RNA-enriched diet: effect on host response and nutritional status. J Parenter Enteral Nutr 1999; 23:314-320.
53. Galban C, Montejo JC, Mesejo A. An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med 2000; 28:643-648.
54. Valero R, Garcia-Valdecasas JC, Net M. L-arginine reduces liver and biliary tract damage after liver transplantation from non-heart beating donor pigs. Transplantation 2000; 15:730-737.
55. Straathof JW, Adamse M, Onkenhout W. Effect of L-arginine on lower oesophageal sphincter motility in man. Eur J Gastroenterol Hepatol 2000; 12:419-424.
56. Nakae H, Endo S, Kikuchi M. Nitrate/nitrite (NOx) levels and hemodynamics during septic shock. Surg Today 2000; 30:683-688.
57. Annane D, Sanquer S, Sebille V. Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet 2000; 355:1143-1148.
58. Johnson ML, Billiar TR. Roles of nitric oxide in surgical infection and sepsis. World J Surg 1998; 22:187-196.
59. Ochoa JB, Udekwu AO, Billiar TR. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214:621-626.
60. Kilbourn RG, Goldfarb RD. Can nitric oxide production be modulated by altering L-arginine levels? Crit Care Med 1999; 27:2586-2587.
61. Kilbourn RG. Nitric oxide synthase inhibitors: a mechanism-based treatment of septic shock. Crit Care Med 1999; 27:857-858.
62. Grover R, Zaccardelli D, Colice G. An open label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: Glaxo Wellcome International Septic Shock Study Group. Crit Care Med 1999; 27:913-922.
63. Avontuur JA, Tutein Nolthenius RP, van Bodegom JW. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study. Crit Care Med 1998; 26:660-667.
64. Lopez A, Lorente JA, Steingrub J. Multiple-center, randomised, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor (546C88): effect on survival in patients with septic shock. Crit Care Med 2004; 32:21-30.
65. Saetre T, Gundersen Y, Smiseth OA, et al. Hepatic oxygen metabolism in porcine endotoxemia: the effect of nitric oxide synthase inhibition. Am J Physiol 1998; 275 (6 Pt 1):G1377-G1385.
66. Saetre T, Gundersen Y, Thiemermann C, et al. Aminoethyl-isothiourea, a selective inhibitor of inducible nitric oxide synthase activity, improves liver circulation and oxygen metabolism in a porcine model of endotoxemia. Shock 1998; 9:109-115.
67. Poeze M, Bruins MJ, Vriens I, et al. Selective iNOS inhibition decreases in vivo NO production, but increases mortality during porcine endotoxemia. Intensive Care Med 2001; 27:S243.
68. Hinder F, Booke M, Traber LD, et al. Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically increased atrial natriuretic peptide. Crit Care Med 1996; 24:131-136.
69. Corbett JA, McDaniel ML. Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes 1992; 41:897-903.
70. Garside P, Hutton AK, Severn A, et al. Nitric oxide mediates intestinal pathology in graft-versus host disease. Eur J Immunol 1992; 22:2141.
71. Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 1997; 94:6954-6958.
72. Xia Y, Dawson VL, Dawson TM, et al. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 1996; 93:6770-6774.
73. Luiking YC, Poeze M, Dejong CH, et al. Sepsis: an arginine deficiency state? Crit Care Med 2004; 32:2135-2145.
74. Bruins MJ, Lamers WH, Meijer AJ, et al. In-vivo measurement of nitric oxide production in porcine gut, liver and muscle during hyperdynamic endotoxemia. Br J Pharmacol 2002; 137:1225-1236.
75. Garcia-Martinez C, Llovera M, Lopez-Soriano FJ, et al. The effects of endotoxin administration on blood amino acid concentrations: similarities with sepsis. Cell Mol Biol 1993; 39:537-542.
76. Milewski PJ, Threlfall CJ, Heath DF, et al. Intracellular free amino acids in undernourished patients with and without sepsis. Clin Sci (Lond) 1982; 62:83-91.
77. Hallemeesch MM, Soeters PB, Deutz NEP. Renal arginine and protein synthesis are increased during early endotoxemia in mice. Am J Physiol Renal Physiol 2002; 282:F316-F323.
78. Luiking Y, Steens L, Poeze M, et al. Low plasma arginine concentration in septic patients is related to diminished de novo arginine production from citrulline. Clin Nutr 2003; 22:S26.
79. Kelly E, Morris SM, Billiar TR. Nitric oxide, sepsis and arginine metabolism. J Parenter Enteral Nutr 1995; 19:234-238.
80. Heyland DK, Novak F, Drover JW, et al. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. J Am Med Ass 2001; 286:944-953.
81. Nieves C Jr, Langkamp-Henken B. Arginine and immunity: a unique perspective. Biomed Pharmacother 2002; 56:471-482.
82. Lorente JA, Landin L, DePablo R, et al. L-arginine pathway in the sepsis syndrome. Crit Care Med 1993; 21:1287-1295.
83. Bruins MJ, Soeters PB, Lamers WH, et al. L-arginine supplementation in hyperdynamic endotoxemic pigs: effect on nitric oxide synthesis by the different organs. Crit Care Med 2002; 30:705-706.
84. Lecleire S, Coeffier M, Leblond J, et al. Modulation of nitric oxide and cytokines production by L-arginine in human gut mucosa. Clin Nutr 2005; 24:353-359. This recent publication provides important data that show that arginine can enhance nitric oxide production in the human gastrointestinal tract.
85. Green LC, de Luzuriaga KR, Wagner DA. Nitrate biosynthesis in man. Proc Natl Acad Sci USA 1981; 82:7764-7767.
86. Moshage H, Kok B, Huizenga JR, et al. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 1995; 41:892-896.
87. Dusse LMS, Morais e Silva RM, Vieira LM, et al. Does plasma nitrite determination by the Griess reaction reflect nitric oxide synthesis? Clin Chim Acta 2005; 362:195-197. An interesting recent publication explaining the advantages and limitations of one of the most commonly used methods for measuring nitric oxide.
88. Wang J, Brown MA, Tam SH, et al. Effects of diet on measurement of nitric oxide metabolites. Clin Exp Pharmacol Physiol 1997; 24:418-420.
89. Moshage H. Nitric oxide determinations: much ado about NO-thing? Clin Chem 1997; 43:553-556.
90. Godkin AJ, De Belder AJ, Villa L, et al. Expression of nitric oxide synthase in ulcerative colitis. Eur J Clin Invest 1996; 26:867-872.
91. Ribbons KA, Zhang X-J, Thompson JH, et al. Potential role of nitric oxide in a model of chronic colitis in rhesus macaques. Gastroenterology 1995; 108:705-711.
92. Rachmilewitz KA, Karmeli D, Eliakim R, et al. Enhanced gastric nitric oxide synthase activity in duodenal ulcer patients. Gut 1994; 35:1394-1397.
93. Archer S. Measurement of nitric oxide in biological models. FASEB J 1993; 7:349-360.
94. Liu X, Liu Q, Gupta E, et al. Quantitative measurements of NO reaction kinetics with a Clark-type electrode. Nitric Oxide 2005; 13:68-77.
95. Kieft H, Roos AN, van Drunen JD, et al. Clinical outcome of immunonutrition in a heterogenous intensive care population. Intensive Care Med 2005; 31:524-532.